Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 3, 2023
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
[ Tue, Oct 03rd 2023
] - WOPRAI
Mon, October 2, 2023
[ Mon, Oct 02nd 2023
] - WOPRAI
[ Mon, Oct 02nd 2023
] - WOPRAI
Joseph Pantginis Maintained (BIOR) at Strong Buy with Decreased Target to $50 on, Oct 2nd, 2023
Joseph Pantginis of HC Wainwright & Co., Maintained "Biora Therapeutics, Inc." (BIOR) at Strong Buy with Decreased Target from $65 to $50 on, Oct 2nd, 2023.
Joseph, nor any peers, have made any analyst calls on BIOR in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30